Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Blaze Systems Releases BlazeLIMS Tobacco Testing Module

Published: Tuesday, July 16, 2013
Last Updated: Monday, July 15, 2013
Bookmark and Share
New add-on module to BlazeLIMS provides a comprehensive testing request submission form.

Blaze Systems has introduced a Tobacco Testing Module as an add-on to its flagship BlazeLIMS Enterprise product. BlazeLIMS provides a comprehensive testing request submission form that embodies FTC, ISO, MASS, Sidestream and other testing regimes in a highly configurable and easy-to-use form, allowing for the entry of complex sets of brands and testing requirements.

The testing request is then automatically translated into the required set of samples, aliquots, analytes, and replicates to execute the complex coupled process of smoking and analysis. All the logging requirements for a multi-brand, multi-regime request may be accomplished in a matter of a few minutes. Additional features of particular interest to the independent testing laboratory include estimates, blinding of brands, and more.

BlazeLIMS also provides the QC support required to manage the incorporation of smoking QC and analytical QC samples, handling each according in the context of both smoking and analytical batches throughout the laboratory process. The analytical demands for tobacco testing are particularly challenging, and BlazeLIMS provides ELN automation and tracking for method execution, including preparation and usage tracking for all reagents and standards as desired to accomplish the paperless lab, as well as flexible batch run management.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Blaze Systems Announces Strategic Partnership with KineMatic
Strategic alliance and reseller agreement between Blaze Systems and Kinematic to provide ELN-LIMS-SDMS-CDS-Instrument integration.
Friday, December 28, 2012
Scientific News
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Connectome Map More Than Doubles Human Cortex’s Known Regions
Researchers at NIH have developed software that automatically detects the “fingerprint” of each of these areas in an individual’s brain scans.
Virus Inspired Cell Cargo Ships
Virus-inspired container design may lead to cell cargo ships following construction of ten large, two-component, icosahedral protein complexes.
Three-Drug Combinations Counter Antibiotic Resistance
Research shows that combinations of three different antibiotics can treat resistant bacteria, even if they are ineffective independently.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Identifying Cancer Drug Targets Using 3D-Modelling
Researchers are now able to model genetic mutations manipulation of proteins that can potentially drive cancer.
Human Evolution Driven by Viruses
Study finds surprising percentage of protein adaptions in humans have been driven by viruses.
Earliest Sign of Alzheimer's Development Discovered
Researchers have identified the first physiological signs of late-onset Alzheimer's disease, underlining the importance of computational power in neurology.
Computational Method Offers Significant Boost in Finding New Cancer Targets
MIT and ARIAD Pharmaceuticals team have identified evidence of significant cancer mutations.
Drug Response Predicted by Cancer Cell Lines
Large-scale study could increase success rate of developing personalised cancer treatments.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!